Andrea S. Blevins Primeau

PhD, MBA

Most Recent Articles by Andrea S. Blevins Primeau

Non-small Cell Lung Cancer Survival Improved With Adoptive Cellular Immunotherapy

Non-small Cell Lung Cancer Survival Improved With Adoptive Cellular Immunotherapy

By

Adjuvant adoptive cellular immunotherapy plus chemotherapy improved survival in patients with resected non-small cell lung caner.

Does CT Scan at Follow-up Improve Resected NSCLC Survival?

Does CT Scan at Follow-up Improve Resected NSCLC Survival?

By

Recommendations to include CT scans as standard follow-up procedure is based on poor evidence.

Improving Survival in Resected NSCLC With Adoptive Cellular Immunotherapy

Improving Survival in Resected NSCLC With Adoptive Cellular Immunotherapy

By

A phase 3 trial examined the efficacy of chemoimunnotherapy vs chemotherapy alone in postsurgical patients with non-small cell lung cancer.

Does Palifosfamide With Platinum Doublet Prolong SCLC Survival?

Does Palifosfamide With Platinum Doublet Prolong SCLC Survival?

By

Palifosfamide added to carboplatin and etoposide did not prolong survival among patients with extensive-stage small-cell lung cancer.

Efficacy of Neoadjuvant Nivolumab in NSCLC

Efficacy of Neoadjuvant Nivolumab in NSCLC

By

Researchers considered the response rate "encouraging" and comparable to cisplatin-based neoadjuvant therapy outcomes.

More Articles by Andrea S. Blevins Primeau

Sign Up for Free e-newsletters